Journal Home > Volume 4 , Issue 1

Hypoxia-inducible factor (HIF) is a main heterodimeric transcription factor that regulates the cellular adaptive response to hypoxia by stimulating the transcription of a series of hypoxia-inducible genes. HIF is frequently upregulated in solid tumors, and the overexpression of HIF can promote tumor progression or aggressiveness by blood vessel architecture and altering cellular metabolism. In this review, we focused on the pivotal role of HIF in tumor angiogenesis and energy metabolism. Furthermore, we also emphasized the possibility of HIF pathway as a potential therapeutic target in cancer.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 21 August 2016
Accepted: 22 November 2016
Published: 14 December 2016
Issue date: March 2017

Copyright

© 2016, Chongqing Medical University.

Acknowledgements

Acknowledgement

This work was supported by National Nature Science Foundation of China (81272960), Key Research Program from Science and Technology Department of Hunan Province, China (2013WK2010 and 2014SK2015). Key Research Program from Ministry of human Resources and Social Security of the People’s Republic of China (2016)176.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return